Emerging Medical Sensing Technologies - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/836550

Emerging Medical Sensing Technologies

Description:

This research service provides an overview of the emerging sensing technologies in the field of healthcare.

This Frost & Sullivan research service titled Emerging Medical Sensing Technologies provides in-depth information about various commercial diagnostic products and biosensing techniques available in the market today and those on the verge of commercialization. It examines the scope of biosensors with respect to their applications across varied healthcare-related areas, including drug delivery, medical devices, and nanomedicine. It aims to increase the market and product awareness among not only key industry participants but also the medical community and the patients themselves. In this research, Frost & Sullivan's expert analysts thoroughly examine the following technologies: non-invasive sensors, invasive devices, nanotechnology-based sensors, diagnostic test kits, and medical devices for medical diagnostic applications.

Market Overview

Biosensors' Efficacy in the Healthcare Industry Drives Advances in Medical Sensing Technologies

The healthcare sector's need for simpler and easier alternative methods of diagnosis, coupled with patients' demand for user-friendly, cost-effective techniques, have given a major impetus to the development of medical sensing technologies such as biosensors. This efficient, compatible, and user-friendly technology, which can detect minute quantities of biochemical or chemical components in a biological medium, has found growing acceptance among a wide range of applications in the field of ailment detection as well as analytical diagnosis. Owing to the increasing impact of nanotechnology as well as microarray and microfluidic technologies, both the medical sensing industry as well as academia are working toward developing new biosensor platforms for pain-free, accurate, and selectively sensitive diagnostic biosensors. A greater number of collaborations between the industry and universities will go a long way in the creation of newer and better biosensors. "Researchers have now designed new-age biosensors that are non-biological elements capable of sensing biological parameters, which means that the sensing element in question works only in presence of the proposed biological element," say the analysts of this research. Such improvements in biosensing are timely, considering the spurt in diseases all over the world due to unhealthy lifestyles, inadequate physical activity, and unreasonable occupational demands.

Despite all these advances, biosensors are still challenged by the limited lifetimes of their biological components since all organic materials, mainly when removed from their natural surroundings, deteriorate with time. "Generally, it has been shown that pour enzymes have the lowest stability and tissue preparations have the longest," notes the analyst. "While analyzing the lifetime of biosensors, three aspects of lifetime can be considered: the lifetime of the biosensor in use, the lifetime of the biosensor in storage, and the lifetime of the biological material stored separately." This being the case, researchers are striving to offer greater automation and convenience through noninvasive diagnostics. They are hoping to extend the longevity of the device by developing implantable yet completely automated and intelligent sensing platforms or sensors. The researchers' progress has attracted an increasing number of companies to this industry, yet the rate of growth is only moderate. This is mainly because being a standardized market, venture capitalists and acquiring companies have the freedom to wait and watch. This cautious approach has affected emerging companies significantly. Any small company with an innovative product, based on a robust technology, will have to be acquired or merge with a larger company to obtain return on investment and ease the commercialization process. This could prove daunting since bigger companies are facing a problem of plenty due to the presence of numerous similar products. The overlapping of technologies and products hinder each other’s potential market.

Once they figure out the companies that are profitable to acquire, large corporates will have to deal with the issue of rapid product obsolescence. This is because even though the rate of R&D is impressive in the biosensor industry, the products' market penetration is sluggish. Moreover, biosensor development – right from the R&D stage up to the production of the prototype product – is prohibitively expensive. "Commercialization of products would require companies to form strategic collaborations such as partnerships with original equipment manufacturers, licensing, and joint ventures," observes the analyst. "However, forming these associations is a time-consuming process and hence, even the newer technologies may seem obsolete to the end users." Researchers are hoping to overcome some of their challenges by developing products with greater unique selling propositions (USPs) by integrating wireless technology into the products as well as focusing on the creation of noninvasive monitoring systems and nanotechnology-based sensing devices.

Technologies

The following technologies are covered in this research:

- Blood analyte monitoring
- Disease detection
- Invasive biosensors
- Non-invasive biosensors
- Test kits

Contents:

1. Executive Summary

Introduction

Emerging Biosensing Technologies and Their Applications

Key Technology Trends

Scope and Methodology

Scope of the Research Service

Research Methodology

2. Biosensors--An Overview

Technology Primer

Basic Description

Categories

Prelude

Performance

Emerging Diagnostic Biosensing System

3. Applications and Analysis

Technology Analysis

Technology Drivers and Restraints

Technology Challenges

Technology Segmentation and the Developer Focus

Competitive Environment for Medical Biosensing

Analyst Insights

Comments

Snapshot

4. Technical Developments

Developments by Companies

Noninvasive Glucose Monitoring--Portable Urine Glucose Meter

Voice-Based Blood Glucose Monitoring for Visually Impaired Diabetics

Intact Protein Microarrays

Real-Time PCR Assay for Respiratory Viruses

Low-Cost Portable Instrument for Testing Inhalable Drug Delivery Devices

DNA-Based Sensors for Detecting Volatile Compounds

TruArray for Rapid Diagnosis of Infectious Diseases

A High-Performance Low-Cost Analytical Device for Semen Analysis

Hologram-Based Sensors for Continuous Monitoring of Blood Glucose

An Innovative Sensor Technology for Quantification of Proteins

In Vivo Analysis of Blood Components

Electrochemical Sensors

Developments by Universities

Glucose Monitoring sans Pain and Blood

Electroanalysis Using Multiwalled Carbon Nanotube Nanoelectrode Arrays

5. Technology: AHP and Future

AHP

Definition of Criteria

AHP Process and Computation for Goal Node and Level 0 Criteria

AHP Process and Computation for Goal Node and Level 1 Criteria

Final Priorities and Analyst Insights

Future Forecast

Mechanistic Overview of Future Developments

Technology Road Map

6. Key Patents; Contacts

Key Patents

WIPO--Biosensor System Patents

WIPO--Allied Patents

Contacts

Database of Key Industry Participants

University Participants

7. Decision Support Database

Database Tables

Incidence of Diabetes by Region (2002—2012)

Percent Healthcare Expenditure in GDP by Region (2002--2012)

Government R & D Expenditure (Mn USD) in Biotechnology by Region (2002-2012)

Per Capita Healthcare Expenditure (USD) by Region (2001--2012)

Prevalence of Diabetes by Region (2002--2012

Total Healthcare Expenditure by Region (2002--2012)

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/836550

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 29/11/2009 06:28:36

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Emerging Medical Sensing Technologies
Web Address:
http://www.researchandmarkets.com/reports/836550
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Site License		€4,365.00
	Electronic and Hard Copy (PDF) - Site License		€4,701.00 + EUR€ 50.00 Shipping/Handling *
	Electronic (PDF) - Enterprisewide		€5,373.00
	Electronic and Hard Copy (PDF) - Enterprisewide		€5,709.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 29/11/2009 06:28:36

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)